Source:http://linkedlifedata.com/resource/pubmed/id/10490738
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1999-10-21
|
pubmed:abstractText |
'.the leukemic stem line is a small minority within the total cell mass;. when the leukemic stem line is not exceeding the normal stem cell numbers, its proliferation may still be under partial control.' LG Lajtha, Blood Cells 1981; 7: 45-62 We performed cytogenetic analysis on fresh bone marrow cells and on progenitor cell colonies in a patient who relapsed after allogeneic BMT for CML and was subsequently treated with donor lymphocyte infusions (DLI). Two Philadelphia-positive clones were identified at relapse. One clone displayed an additional chromosomal abnormality most likely induced by radio-chemotherapy and therefore arising in a single cell. This cell displays the characteristics of a stem cell, since it was able to support 20% of Ph-positive hemopoiesis for 5 months. If the progeny of a single Ph-positive stem cell account for 20% of hemopoiesis, a very low number of leukemic stem cells may sustain relapse after allogeneic BMT. This is in keeping with two observations: (1) at relapse, long-term culture initiating cells (LTC-IC) were all donor-derived and Ph-negative; (2) on average, the pace of the disease is very slow after relapse following allogeneic-BMT. Therefore, we hypothesize that a small number of leukemic stem cells may be involved in the initial events of relapse following BMT for CML.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0268-3369
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
689-91
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10490738-Bone Marrow Transplantation,
pubmed-meshheading:10490738-Graft vs Host Disease,
pubmed-meshheading:10490738-Humans,
pubmed-meshheading:10490738-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:10490738-Lymphocyte Transfusion,
pubmed-meshheading:10490738-Neoplastic Stem Cells,
pubmed-meshheading:10490738-Recurrence,
pubmed-meshheading:10490738-Transplantation, Homologous
|
pubmed:year |
1999
|
pubmed:articleTitle |
Relapse after allogeneic BMT for chronic myeloid leukemia (CML) may be sustained by a small number of leukemic 'stem cells': a hypothesis.
|
pubmed:affiliation |
Divisione Ematologia Ospedale San Martino, Genova, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|